CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy

BACKGROUND: Locally advanced breast cancer often undergoes neoadjuvant chemotherapy (NAC), which allows in vivo evaluation of the therapeutic response. The determination of the pathological complete response (pCR) is one way to evaluate the response to neoadjuvant chemotherapy. However, the rate of...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:BMC Cancer
Main Authors: Alves, Wilson Eduardo Furlan Matos, Bonatelli, Murilo, Dufloth, Rozany, Kerr, Lígia Maria, Carrara, Guilherme Freire Angotti, da Costa, Ricardo Filipe Alves, Scapulatempo-Neto, Cristovam, Tiezzi, Daniel, da Costa Vieira, René Aloísio, Pinheiro, Céline
Formáid: Artigo
Teanga:Inglês
Foilsithe: BioMed Central 2019
Ábhair:
Research Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889185/
https://ncbi.nlm.nih.gov/pubmed/31795962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6353-2
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla